Bruker (BRKR) Operating Margin Growth (3y) (2013 - 2026)
Bruker (BRKR) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 2,016.00 |
| 10 | Bruker | 9.16 Bn | 9.16 Bn | 379.80 Mn | -1,667.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,667.00 |
| Dec 31, 2025 | -2,162.00 |
| Sep 30, 2025 | -2,657.00 |
| Jun 30, 2025 | -1,107.00 |
| Mar 31, 2025 | -1,225.00 |
| Dec 31, 2024 | -1,099.00 |
| Sep 30, 2024 | -1,071.00 |
| Jun 30, 2024 | -899.00 |
| Mar 31, 2024 | -708.00 |
| Dec 31, 2023 | -586.00 |
| Sep 30, 2023 | 88.00 |
| Jun 30, 2023 | 372.00 |
| Mar 31, 2023 | 1,404.00 |
| Dec 31, 2022 | -113.00 |
| Sep 30, 2022 | 370.00 |
| Jun 30, 2022 | 165.00 |
| Mar 31, 2022 | 714.00 |
| Dec 31, 2021 | -87.00 |
| Sep 30, 2021 | 378.00 |
| Jun 30, 2021 | 400.00 |